Article Details
Retrieved on: 2022-06-21 14:43:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
9 Meters Biopharma Inc (NASDAQ: NMTR) completed a pre-specified interim analysis for the Phase 3 study of larazotide for patients with celiac ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here